Can lithium or valproate untie tangles in Alzheimer's disease?

Journal of Clinical Psychiatry

Volumn 70, Issue 6, 2009, Pages 919-921

  Tariot, Pierre N ^a,c   Aisen, Paul S ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BANNER ALZHEIMER S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; NERVE GROWTH FACTOR; TAU PROTEIN; VALPROIC ACID;

ALZHEIMER DISEASE; CELL CYCLE REGULATION; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; GENE MUTATION; HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOSPHORYLATION; PRIORITY JOURNAL; SHORT SURVEY; SYNAPTOGENESIS;

AGED; ALZHEIMER DISEASE; ANTICONVULSANTS; BRAIN; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CARBONATE; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENILE PLAQUES; TAU PROTEINS; VALPROIC ACID;

EID: 67649199941     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09com05331     Document Type: Short Survey

References (6)

1. Hampel H, Ewers M, Bürger K, et al. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry. 2009;7(6):922-931.
2. Alzheimer's Association, 2009 Facts and Figures. Alzheimers Dement. 2009;5(3). In press.
3. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998;55(3):326-335. (Pubitemid 28146197)
4. Churcher I. Tau therapeutic strategies for the treatment of Alzheimer's disease. Curr Top Med Chem. 2006;6(6):579-595.
5. Tariot PN, Raman R, Jakimovich L, et al. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry. 2005;13(11):942-949. (Pubitemid 46638660)
6. Tariot PN, Loy R, Ryan JM, et al. Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales. Adv Drug Deliv Rev. 2002;54(12):1567-1577. (Pubitemid 35346831)